General Info

Founded in 2004, Magellan Biosciences was established through the combination of ESA Biosciences and Dynex Technologies, two dynamic companies that address emerging growth markets in biomedical research and clinical diagnostics. It develops and commercializes worldwide a range of products that improve clinical outcomes, including point-of-care assays and analyzers, automated clinical-assay workstations, diagnostic systems and assays, and related consumables and services. Headquartered about 30 miles northwest of Boston in Chelmsford, Mass., the company employs a multidisciplinary staff of more than 300 employees worldwide who work cross-functionally to provide quick response to customers and to solve complex product-development and technical-support problems. Magellan Biosciences is a privately held company that serves customers through its wholly owned subsidiaries, including ESA Biosciences, Dynex Technologies and TREK Diagnostic Systems.